These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1224148)

  • 1. Chloroquine myopathy.
    Ionescu M; Alexianu M; Luca N; Petrovici A; Plăiaşu D; Voiculescu V
    Neurol Psychiatr (Bucur); 1975; 13(4):319-23. PubMed ID: 1224148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical studies on experimental chloroquine myopathy].
    Sano M
    Rinsho Shinkeigaku; 1985 May; 25(5):627-35. PubMed ID: 4028583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental chloroquine myopathy--morphological and biochemical studies].
    Kumamoto T; Araki S; Toyoshima I; Fukuhara N
    Rinsho Shinkeigaku; 1984 May; 24(5):505-12. PubMed ID: 6478718
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental chloroquine myopathy.
    Macdonald RD; Engel AG
    J Neuropathol Exp Neurol; 1970 Jul; 29(3):479-99. PubMed ID: 4247107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies on the etiology of nitrofurane-induced polyneuropathy and histopathology of chlorochindiphosphate (Resochin) neuro-myopathy].
    Klinghardt GW
    Beitr Neurochir; 1970; 16():55-61. PubMed ID: 4246650
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroquine myopathy.
    Hughes JT; Esiri M; Oxbury JM; Whitty CW
    Q J Med; 1971 Jan; 40(157):85-93. PubMed ID: 4253656
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
    Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
    Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental chloroquine myopathy: morphological and biochemical studies.
    Kumamoto T; Araki S; Watanabe S; Ikebe N; Fukuhara N
    Eur Neurol; 1989; 29(4):202-7. PubMed ID: 2759144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental myopathy induced by amphiphilic cationic compounds including several psychotropic drugs.
    Drenckhahn D; Lüllmann-Rauch R
    Neuroscience; 1979; 4(4):549-62. PubMed ID: 34807
    [No Abstract]   [Full Text] [Related]  

  • 10. Chloroquine myopathy and myasthenia-like syndrome.
    Sghirlanzoni A; Mantegazza R; Mora M; Pareyson D; Cornelio F
    Muscle Nerve; 1988 Feb; 11(2):114-9. PubMed ID: 3343986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle expression of clathrin and mannose 6-phosphate receptor in experimental chloroquine-induced myopathy.
    Masuda T; Ueyama H; Nakamura K; Jikumaru M; Toyoshima I; Kumamoto T
    Muscle Nerve; 2005 Apr; 31(4):495-502. PubMed ID: 15712280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of a cysteine proteinase inhibitor, EST, in experimental chloroquine myopathy in rats.
    Sugita H; Higuchi I; Sano M; Ishiura S
    Muscle Nerve; 1987; 10(6):516-23. PubMed ID: 3306368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy.
    Suzuki T; Nakagawa M; Yoshikawa A; Sasagawa N; Yoshimori T; Ohsumi Y; Nishino I; Ishiura S; Nonaka I
    J Biochem; 2002 May; 131(5):647-51. PubMed ID: 11983070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental neuropathology and clinical neurology of chloroquine side effects.
    Klinghardt GW
    Int J Neurol; 1978; 11(4):331-41. PubMed ID: 397203
    [No Abstract]   [Full Text] [Related]  

  • 15. Chloroquine myopathy.
    Br Med J; 1971 Jun; 2(5762):605. PubMed ID: 5580719
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chloroquine neuromyopathy. One case in prophylactic maleriatherapy (author's transl)].
    Lhermitte F; Marteau R; Chedru F; Mallecourt J; Estrade G; Godet-Guillain J; Chevallay M
    Nouv Presse Med; 1977 Oct; 6(35):3205-7. PubMed ID: 200890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports].
    Becerra-Cuñat JL; Coll-Cantí J; Gelpí-Mantius E; Ferrer-Avellí X; Lozano-Sánchez M; Millán-Torné M; Ojanguren I; Ariza A; Olivé A
    Rev Neurol; 2003 Mar 16-31; 36(6):523-6. PubMed ID: 12652413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine-induced myopathy.
    Chapman RS; Ewen SW
    Br J Dermatol; 1969 Mar; 81(3):217-9. PubMed ID: 5775072
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe, reversible dysphagia from chloroquine and hydroxychloroquine myopathy.
    Mateen FJ; Keegan BM
    Can J Neurol Sci; 2007 Aug; 34(3):377-9. PubMed ID: 17803043
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic effect of cysteine proteinase inhibitor, EST, on experimental chloroquine myopathy].
    Higuchi I; Ishiura S; Sugita H; Ii K; Katunuma N
    Rinsho Shinkeigaku; 1986 Sep; 26(9):928-36. PubMed ID: 3491718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.